azilsartan was found
to be about 5 to 20 times more potent than irbesartan and
valsartan, respectively. The greater potency of azilsartan for
AT1
receptor blockade could help explain why azilsartan lowers
BP more than maximum approved doses of other ARBs
such as olmesartan and valsartan